1. I have read in some older material that Sarepta were originally experimenting with CPP’s derived from viruses. does anyone know if the CPP they used recently was derived from the same source?
PYC always goes to some effort to always use the expression ‘non viral’ CPP’s in the methodology they use.
I think that the FDA must be more comfortable with a nature derived protein fragment (I.e. not AI derived synthetic) than a nasty piece of a virus.
2. I think you may also find Sue Fletcher moved from Murdoch/Sarepta because she viewed PYC may have had a more diversified choice of CPP delivery mechanisms … as well as the Covid virus at the time had materially reduced the budgets she (and her team of young emerging genius scientists) would have staying at Murdoch University. PYC now employs 64 from recollection
full credit must go to Rohan Hockings to identify and then execute quickly such a brilliant coupe
PYC Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)